Cargando…

Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast Cancer—Design, Synthesis, and In Vitro Evaluation

[Image: see text] The epidermal growth factor receptor (EGFR) is vital for regulating cellular functions, including cell division, migration, survival, apoptosis, angiogenesis, and cancer. EGFR overexpression is an ideal target for anticancer drug development as it is absent from normal tissues, mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nada, Hossam, Gul, Anam Rana, Elkamhawy, Ahmed, Kim, Sungdo, Kim, Minkyoung, Choi, Yongseok, Park, Tae Jung, Lee, Kyeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483653/ https://www.ncbi.nlm.nih.gov/pubmed/37692247 http://dx.doi.org/10.1021/acsomega.3c02799

Ejemplares similares

Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies
por: Elkamhawy, Ahmed, et al.
Publicado: (2022)

Identification of Potent hDHODH Inhibitors for Lung Cancer via Virtual Screening of a Rationally Designed Small Combinatorial Library
por: Nada, Hossam, et al.
Publicado: (2023)

Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure–Activity Relationship (SAR)
por: Godesi, Sreenivasulu, et al.
Publicado: (2023)

Cantharidin-Based Verbenone Derivatives as a Novel Insecticide against Plutella xylostella: Design, Synthesis, Insecticidal Activity Evaluation, and 3D QSAR Study
por: Lee, Kwanshik, et al.
Publicado: (2023)

Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines
por: Son, Seohyun, et al.
Publicado: (2023)

4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies
por: Nada, Hossam, et al.
Publicado: (2022)

Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
por: Godesi, Sreenivasulu, et al.
Publicado: (2023)

Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations
por: Nada, Hossam, et al.
Publicado: (2022)

Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation Studies
por: Lee, Kyeong, et al.
Publicado: (2021)

Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations
por: Elkamhawy, Ahmed, et al.
Publicado: (2023)

Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer
por: Nada, Hossam, et al.
Publicado: (2021)

Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Integration of Hybridization Strategies in Pyridine–Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights
por: Godesi, Sreenivasulu, et al.
Publicado: (2023)

Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity
por: Elsherbeny, Mohamed H., et al.
Publicado: (2021)

Structure-based design and synthesis of a novel long-chain 4′′-alkyl ether derivative of EGCG as potent EGFR inhibitor: in vitro and in silico studies
por: Singh, Satyam, et al.
Publicado: (2022)

Identification of Novel Aryl Carboxamide Derivatives as Death-Associated Protein Kinase 1 (DAPK1) Inhibitors with Anti-Proliferative Activities: Design, Synthesis, In Vitro, and In Silico Biological Studies
por: Elkamhawy, Ahmed, et al.
Publicado: (2022)

Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment
por: Le, Yi, et al.
Publicado: (2020)

Synthesis and in Vitro Screening of Phenylbipyridinylpyrazole Derivatives as Potential Antiproliferative Agents
por: Al-Sanea, Mohammad M., et al.
Publicado: (2015)

Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress
por: Elsherbeny, Mohamed H., et al.
Publicado: (2021)

Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo
por: Lai, Mengzhen, et al.
Publicado: (2023)

Identification of Potent EGFR Inhibitors from TCM Database@Taiwan
por: Yang, Shun-Chieh, et al.
Publicado: (2011)

Saccharomonosporine A inspiration; synthesis of potent analogues as potential PIM kinase inhibitors
por: AboulMagd, Asmaa M., et al.
Publicado: (2020)

Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers
por: El-Kalyoubi, Samar, et al.
Publicado: (2023)

Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization
por: Bajracharya, Rajiv, et al.
Publicado: (2019)

Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives
por: Li, Meng, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
por: Al-Wahaibi, Lamya H., et al.
Publicado: (2022)

Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer
por: Dera, Ayed A., et al.
Publicado: (2023)

New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation
por: Dastyafteh, Navid, et al.
Publicado: (2023)

Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus
por: Sokolova, A. S., et al.
Publicado: (2017)

New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
por: Mahalapbutr, Panupong, et al.
Publicado: (2022)

Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors
por: Chu, Guo-Hua, et al.
Publicado: (2009)

Design and Synthesis of N-phenyl Phthalimides as Potent Protoporphyrinogen Oxidase Inhibitors
por: Gao, Wei, et al.
Publicado: (2019)

Design, synthesis and biological evaluation of a series of dianilinopyrimidines as EGFR inhibitors
por: Yan, Longjia, et al.
Publicado: (2022)

Design, synthesis and antitumor activity of 5-trifluoromethylpyrimidine derivatives as EGFR inhibitors
por: Zuo, Yaqing, et al.
Publicado: (2022)

Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Design, synthesis, in vitro, and in silico evaluations of kojic acid derivatives linked to amino pyridine moiety as potent tyrosinase inhibitors
por: Rezapour Niri, Davood, et al.
Publicado: (2023)

In vitro and in vivo pharmacokinetic characterization of LMT-28 as a novel small molecular interleukin-6 inhibitor
por: Ahn, Sung-Hoon, et al.
Publicado: (2020)

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors
por: Tu, Yuanbiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o0uvjl97p1ai7s7u3108j42sjk